4//SEC Filing
Akebia Therapeutics, Inc. 4
Accession 0001562180-17-000882
$AKBACIK 0001517022operating
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:02 PM ET
Size
7.3 KB
Accession
0001562180-17-000882
Insider Transaction Report
Form 4
Tubridy Karen L
SVP, Chief Development Officer
Transactions
- Award
Stock Option (Right to buy)
2017-02-21$10.14/sh+36,500$370,110→ 36,500 totalExercise: $0.00Exp: 2027-02-21→ Common Stock (36,500 underlying) - Award
Common Stock
2017-02-21+23,000→ 23,000 total
Footnotes (2)
- [F1]The restricted stock units were granted by the Issuer pursuant to its 2014 Incentive Plan. One hundred percent of the restricted stock units will vest on the third anniversary of the grant date.
- [F2]25% of the shares underlying this option will vest on the first anniversary of the grant date with the remaining 75% vesting in equal quarterly installments thereafter.
Documents
Issuer
Akebia Therapeutics, Inc.
CIK 0001517022
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001517022
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:02 PM ET
- Size
- 7.3 KB